ChemicalBook Chinese Germany Japanese Korean

重庆康施恩化工有限公司 Company Information

Company Name:    ChongQing Conscience Pharmaceuticals Ltd.
Tel:    023-68549356;68548079
Email:    clive.yang@consciencepharma.com
Nationality:    China
WebSite:    www.chemicalbook.com/ShowSupplierProductsList16833/0.htm
Product List:    28
1

Product List
(R)-3-PiperidinaMine dihydrochloride 334618-23-4
(S)-isopropyl2-(((S)-(perfluorophenoxy)-(phenoxy)phosphoryl)amino)propanoate 1334513-02-8
(S)-N-Boc-3-hydroxyadaMantylglycine 361442-00-4
(S)-pyrrolidine-2-carboxamide 7531-52-4
(S)-tert-butyl 2-carbamoyl-2,3-dihydropyrrole-1-carboxylate 709031-38-9
2-CHLORO-N-METHOXY-N-METHYLACETAMIDE 67442-07-3
DichlorophenyliMidazoldioxolan 67914-69-6
(2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl) 1378388-16-9
Velpatasvir intermediate 1378388-20-5
N-(L)-alanyl-L-glutamine;BG 39537-23-0
3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro-2'-C-Methyluridine 863329-65-1
NXL104 1192491-61-4
(2S,3R)-Ethyl 3-((R)-2,2-diMethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-Methylpropanoate 93635-76-8
(R)-2-(methoxycarbonylamino)-2-phenylacetic acid 50890-96-5
(2S,5S)-1-((S)-2-(methoxycarbonyl)-3-methylbutanoyl) 1416134-40-9
Velpatasvir intermediate 1438383-89-1
Velpatasvir 1377049-84-7
Tert-Butyl(2S,4S)-2-(4-(2-((2S,5S)-1-((methoxycarbonyl) 1378391-45-7
(6S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid 1129634-44-1
(S)-tert-butyl 6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane-5-carboxylate;ledipasvir interMediate 1441670-89-8
1-(7-broMo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone 1378387-81-5
sofosbuvir 1190307-88-0
(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide 1192651-49-2
(1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid 1256387-74-2
N4,3',5'-tri-O-benzoyl-2'-deoxy-2'-fluoro-2'-C-Methylcytidine 817204-32-3
(2'R)-2'-Deoxy-2'-fluoro-2'-Methyluridine 863329-66-2
bedaquinline 843663-66-1
(2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxamide 1416134-49-0
1

Copyright 2007©  ChemicalBook. All rights reserved.